N-acetylation and ubiquitin-independent proteasomal degradation of p21 Cip1

Molecular Cell

Volumn 16, Issue 5, 2004, Pages 839-847

  Chen, Xueyan ^a,b   Chi, Yong ^c   Bloecher, Andrew ^b   Aebersold, Ruedi ^c   Clurman, Bruce E ^b   Roberts, James M ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYSINE; PROTEASOME; PROTEIN P21; UBIQUITIN;

ACETYLATION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN DEGRADATION; UBIQUITINATION;

ACETYLATION; ANIMALS; CELL CYCLE PROTEINS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLOHEXIMIDE; FIBROBLASTS; GENE EXPRESSION REGULATION; LYSINE; MICE; PLASMIDS; POLYMERASE CHAIN REACTION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN SYNTHESIS INHIBITORS; RETROVIRIDAE; S-PHASE KINASE-ASSOCIATED PROTEINS; TEMPERATURE; TIME FACTORS; TRANSFECTION; UBIQUITIN;

ANIMALIA;

EID: 9744227998     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2004.11.011     Document Type: Article

References (40)

1. Bendjennat M., Boulaire J., Jascur T., Brickner H., Barbier V., Sarasin A., Fotedar A., Fotedar R. UV irradiation triggers ubiquitin-dependent degradation of p21(WAF1) to promote DNA repair. Cell. 114:2003;599-610
2. Blagosklonny M.V., Wu G.S., Omura S., el-Deiry W.S. Proteasome-dependent regulation of p21WAF1/CIP1 expression. Biochem. Biophys. Res. Commun. 227:1996;564-569
3. Bloom J., Amador V., Bartolini F., DeMartino G., Pagano M. Proteasome-mediated degradation of p21 via N-terminal ubiquitylation. Cell. 115:2003;71-82
4. Bornstein G., Bloom J., Sitry-Shevah D., Nakayama K., Pagano M., Hershko A. Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J. Biol. Chem. 278:2003;25752-25757
5. Bradshaw R.A., Brickey W.W., Walker K.W. N-terminal processing. the methionine aminopeptidase and N alpha-acetyl transferase families Trends Biochem. Sci. 23:1998;263-267
6. Chowdary D.R., Dermody J.J., Jha K.K., Ozer H.L. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol. Cell. Biol. 14:1994;1997-2003
7. Clurman B.E., Sheaff R.J., Thress K., Groudine M., Roberts J.M. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10:1996;1979-1990
8. Coleman M.L., Marshall C.J., Olson M.F. Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation. EMBO J. 22:2003;2036-2046
9. Coulombe P., Rodier G., Bonneil E., Thibault P., Meloche S. N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome. Mol. Cell. Biol. 24:2004;6140-6150
10. Diehl J.A., Zindy F., Sherr C.J. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11:1997;957-972
11. Dores R.M., McDonald L.K., Steveson T.C., Sei C.A. The molecular evolution of neuropeptides. prospects for the '90s Brain Behav. Evol. 36:1990;80-99
12. Driessen H.P., de Jong W.W., Tesser G.I., Bloemendal H. The mechanism of N-terminal acetylation of proteins. CRC Crit. Rev. Biochem. 18:1985;281-325
13. Dynlacht B.D., Ngwu C., Winston J., Swindell E.C., Elledge S.J., Harlow E., Harper J.W. Purification and analysis of CIP/KIP proteins. Methods Enzymol. 283:1996;230-244
14. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825
15. Giandomenico V., Simonsson M., Gronroos E., Ericsson J. Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors. Mol. Cell. Biol. 23:2003;2587-2599
16. Grandori C., Wu K.J., Fernandez P., Ngouenet C., Grim J., Clurman B.E., Moser M.J., Oshima J., Russell D.W., Swisshelm K., et al. Werner syndrome protein limits MYC-induced cellular senescence. Genes Dev. 17:2003;1569-1574
17. Griffin T.J., Lock C.M., Li X.J., Patel A., Chervetsova I., Lee H., Wright M.E., Ranish J.A., Chen S.S., Aebersold R. Abundance ratio-dependent proteomic analysis by mass spectrometry. Anal. Chem. 75:2003;867-874
18. Gronroos E., Hellman U., Heldin C.H., Ericsson J. Control of Smad7 stability by competition between acetylation and ubiquitination. Mol. Cell. 10:2002;483-493
19. Handeli S., Weintraub H. The ts41 mutation in Chinese hamster cells leads to successive S phases in the absence of intervening G2, M, and G1. Cell. 71:1992;599-611
20. Jin Y., Lee H., Zeng S.X., Dai M.S., Lu H. MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation. EMBO J. 22:2003;6365-6377
21. Kendall R.L., Yamada R., Bradshaw R.A. Cotranslational amino-terminal processing. Methods Enzymol. 185:1990;398-407
22. Kuo M.L., den Besten W., Bertwistle D., Roussel M.F., Sherr C.J. N-terminal polyubiquitination and degradation of the Arf tumor suppressor. Genes Dev. 18:2004;1862-1874
23. Lammer D., Mathias N., Laplaza J.M., Jiang W., Liu Y., Callis J., Goebl M., Estelle M. Modification of yeast Cdc53p by the ubiquitin-related protein rub1p affects function of the SCFCdc4 complex. Genes Dev. 12:1998;914-926
24. Nakayama K., Ishida N., Shirane M., Inomata A., Inoue T., Shishido N., Horii I., Loh D.Y. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 85:1996;707-720
25. Nakayama K., Nagahama H., Minamishima Y.A., Matsumoto M., Nakamichi I., Kitagawa K., Shirane M., Tsunematsu R., Tsukiyama T., Ishida N., et al. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J. 19:2000;2069-2081
26. Nishitani H., Goto H., Kaneda S., Yamao F., Seno T., Handley P., Schwartz A.L., Nishimoto T. tsBN75 and tsBN423, temperature-sensitive x-linked mutants of the BHK21 cell line, can be complemented by the ubiquitin-activating enzyme E1 cDNA. Biochem. Biophys. Res. Commun. 184:1992;1015-1021
27. Ohh M., Kim W.Y., Moslehi J.J., Chen Y., Chau V., Read M.A., Kaelin W.G. Jr. An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells. EMBO Rep. 3:2002;177-182
28. Pagano M., Tam S.W., Theodoras A.M., Beer-Romero P., Del Sal G., Chau V., Yew P.R., Draetta G.F., Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 269:1995;682-685
29. Parker S.B., Eichele G., Zhang P., Rawls A., Sands A.T., Bradley A., Olson E.N., Harper J.W., Elledge S.J. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science. 267:1995;1024-1027
30. Polevoda B., Sherman F. Nalpha-terminal acetylation of eukaryotic proteins. J. Biol. Chem. 275:2000;36479-36482
31. Polevoda, B., and Sherman, F. (2002). The diversity of acetylated proteins. Genome Biol. 3, reviews0006.
32. Polevoda B., Sherman F. N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins. J. Mol. Biol. 325:2003;595-622
33. Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 75:1993;495-505
34. Sheaff R.J., Singer J.D., Swanger J., Smitherman M., Roberts J.M., Clurman B.E. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol. Cell. 5:2000;403-410
35. Sherman F., Stewart J.W., Tsunasawa S. Methionine or not methionine at the beginning of a protein. Bioessays. 3:1985;27-31
36. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163
37. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68:1996;850-858
38. Smith C.M., Gafken P.R., Zhang Z., Gottschling D.E., Smith J.B., Smith D.L. Mass spectrometric quantification of acetylation at specific lysines within the amino-terminal tail of histone H4. Anal. Biochem. 316:2003;23-33
39. Touitou R., Richardson J., Bose S., Nakanishi M., Rivett J., Allday M.J. A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J. 20:2001;2367-2375
40. Xirodimas D.P., Saville M.K., Bourdon J.C., Hay R.T., Lane D.P. Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell. 118:2004;83-97